Compounds > lapatinib
Page last updated: 2024-09-05

lapatinib and Carcinogenesis

lapatinib has been researched along with Carcinogenesis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, H; Song, Q; Yang, Y; Yu, X; Yu, Y1
Asztalos, S; Bellis, AD; Bluver, D; Broadbelt, LJ; Dubbury, SJ; Jeruss, JS; Mui, MD; Peñalver Bernabé, B; Saez-Rodriguez, J; Shea, LD; Shin, S; Tonetti, DA; Weiss, MS1
Abt, MA; Hill, EG; Yeh, ES1
Datta, J; Lang, JC; Mapp, AK; Pan, Q; Piao, L; Teknos, TN; Xie, X; Zhang, M1

Other Studies

4 other study(ies) available for lapatinib and Carcinogenesis

ArticleYear
miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer.
    International journal of molecular medicine, 2018, Volume: 42, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Male; MicroRNAs; Middle Aged; Quinazolines; Receptor, ErbB-2; Receptor, Fibroblast Growth Factor, Type 2; Stomach Neoplasms

2018
Dynamic transcription factor activity and networks during ErbB2 breast oncogenesis and targeted therapy.
    Integrative biology : quantitative biosciences from nano to macro, 2014, Volume: 6, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Survival; Computer Simulation; Female; Humans; Lapatinib; Models, Biological; Molecular Targeted Therapy; Protein Array Analysis; Quinazolines; Transcription Factors; Transcriptional Activation

2014
Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.
    Breast cancer research and treatment, 2015, Volume: 149, Issue:1

    Topics: Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Autophagy; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mammary Neoplasms, Animal; Molecular Targeted Therapy; Protein Serine-Threonine Kinases; Quinazolines; Receptor, ErbB-2; Trastuzumab

2015
miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

    Topics: Afatinib; Animals; Antineoplastic Agents; Base Sequence; Carcinogenesis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; ErbB Receptors; Gene Expression; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lapatinib; Mice, Nude; MicroRNAs; Neoplasm Transplantation; Proto-Oncogene Proteins c-ets; Quinazolines; RNA Interference; Signal Transduction; Transcription Factors; Tumor Burden

2015